Edit Content

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Lung Cancer Diagnostics Market to reach USD XX billion by the end of 2030

Global Lung Cancer Diagnostics Market Size study & Forecast, by Cancer Type (Small Cell Lung Cancer, Non-small Cell Lung Cancer), by Test (Imaging Test, Biopsy, Sputum Cytology, Molecular Testing), by End User (Hospitals, Specialty Clinics, Others) and Regional Analysis, 2023-2030

Product Code: HLSMD-22721248
Publish Date: 15-11-2023
Page: 200

Global Lung Cancer Diagnostics Market is valued at approximately USD XX billion in 2022 and is anticipated to grow with a healthy growth rate of more than X% over the forecast period 2023-2030. Lung cancer occurs when cells grow uncontrollably, resulting in the formation of masses called tumors. It can start in any area of the lung, but most cases originate from the cells lining the airways, such as the bronchi and bronchioles. Therefore, lung cancer is often referred to as bronchogenic cancer or bronchogenic carcinoma. The market for lung cancer diagnostics is expanding due to advanced technologies that increase early detection of the disease. However, market growth is challenged by high testing costs and strict regulations for cancer diagnostic products.

The market is propelling due to the rise in prevalence of lung cancer. According to a report published by cancer.net, the prevalence of lung cancer is on the rise, making it the second most common cancer in both men and women in the U.S. In 2021, there were an estimated 228,820 new cases and 135,720 deaths from the disease. The five-year survival rate for lung cancer is only 18%, which is lower than other types of cancer. It is predicted that 127,070 deaths from lung cancer would occur in the United States in 2023, and globally, an estimated 1,796,144 deaths were attributed to the disease in 2020. The development of new and innovative diagnostic technologies, such as non-invasive methods such as CT scans and PET scans, has improved the accuracy and efficiency of early lung cancer detection. Additionally, government initiatives towards diagnosis and detection of cancer are creating more opportunities for the market to grow. However, a lack of skilled and well-trained professionals hinder market growth during the forecast period of 2023-2030.

The key regions considered for the Global Lung Cancer Diagnostics Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the high market penetration rates of technologically advanced products, the rising patient awareness, and the rising smoking prevalence level. According to the Centers for Disease Control and Prevention (CDC) in 2021, reported that nearly 12 of every 100 U.S. adults aged 18 years or older (11.5%) are cigarette smokers. This means an around 28.3 million adults in the United States currently smoke. Initiatives, such as smoking cessation programs conducted by the American Lung Association (ALA) and campaigns to increase awareness of the symptoms of lung cancer are expected to further boost the regional market growth. Asia Pacific is expected to grow significantly over the forecast period, driven by rising penetration of advanced lung cancer diagnostic tools and increasing awareness of disease symptoms.

Major market player included in this report are:
F. Hoffmann-La Roche Ltd.
Thermo Fisher Scientific Inc.
Abbott Laboratories
Quest Diagnostics Incorporated
Biodesix Inc.
Amoy Diagnostics Co., Ltd.
Bio-Rad Laboratories, Inc.
Boditech Med Inc.

Recent Developments in the Market:
Ø In March 2023, Roche received approval from the U.S. FDA for VENTANA PD-L1 (SP263) Assay, to identify non-small cell lung cancer (NSCLC) patients for Libtayo treatment.
Ø In March 2023, Agilent Technologies Inc. acquired Resolution Bioscience Inc. to expand the NGS-based cancer treatment capabilities. This acquisition is aimed to strengthen Agilent’s position in the market.
Ø In October 2022, Quest Diagnostics announced a new partnership with Decode Health. This has helped the company in decreasing the time and expense involved in creating fresh diagnostic tests and finding new medication targets for various cancers.
Ø In August 2022, F. Hoffmann-La Roche Ltd. launched a Digital LightCycler System, a next-generation digital PCR system designed for laboratories performing highly sensitive and precise DNA and RNA analysis in oncology and infectious diseases.

Global Lung Cancer Diagnostics Market Report Scope:
ü Historical Data – 2020 – 2021
ü Base Year for Estimation – 2022
ü Forecast period – 2023-2030
ü Report Coverage – Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
ü Segments Covered – Cancer Type, Test, End User, Region
ü Regional Scope – North America; Europe; Asia Pacific; Latin America; Middle East & Africa
ü Customization Scope – Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Cancer Type:
Small Cell Lung Cancer
Non-small Cell Lung Cancer

By Test:
Imaging Test
Sputum Cytology
Molecular Testing

By End User:
Specialty Clinics

By Region:

North America


Asia Pacific
South Korea

Latin America

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Lung Cancer Diagnostics Market, by Region, 2020-2030 (USD Billion)
1.2.2. Lung Cancer Diagnostics Market, by Cancer Type, 2020-2030 (USD Billion)
1.2.3. Lung Cancer Diagnostics Market, by Test, 2020-2030 (USD Billion)
1.2.4. Lung Cancer Diagnostics Market, by End User, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Lung Cancer Diagnostics Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Lung Cancer Diagnostics Market Dynamics
3.1. Lung Cancer Diagnostics Market Impact Analysis (2020-2030)
3.1.1. Market Drivers Increasing awareness of lung cancer Rise in prevalence of lung cancer
3.1.2. Market Challenges High Cost for Diagnostics and strict regulations Lack of skilled and certified professionals
3.1.3. Market Opportunities Technological advancements Government initiatives towards cancer diagnostic
Chapter 4. Global Lung Cancer Diagnostics Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Lung Cancer Diagnostics Market, by Cancer Type
5.1. Market Snapshot
5.2. Global Lung Cancer Diagnostics Market by Cancer Type, Performance – Potential Analysis
5.3. Global Lung Cancer Diagnostics Market Estimates & Forecasts by Cancer Type 2020-2030 (USD Billion)
5.4. Lung Cancer Diagnostics Market, Sub Segment Analysis
5.4.1. Small Cell Lung Cancer
5.4.2. Non-small Cell Lung Cancer
Chapter 6. Global Lung Cancer Diagnostics Market, by Test
6.1. Market Snapshot
6.2. Global Lung Cancer Diagnostics Market by Test, Performance – Potential Analysis
6.3. Global Lung Cancer Diagnostics Market Estimates & Forecasts by Test 2020-2030 (USD Billion)
6.4. Lung Cancer Diagnostics Market, Sub Segment Analysis
6.4.1. Imaging Test
6.4.2. Biopsy
6.4.3. Sputum Cytology
6.4.4. Molecular Testing
Chapter 7. Global Lung Cancer Diagnostics Market, by End User
7.1. Market Snapshot
7.2. Global Lung Cancer Diagnostics Market by End User, Performance – Potential Analysis
7.3. Global Lung Cancer Diagnostics Market Estimates & Forecasts by End User 2020-2030 (USD Billion)
7.4. Lung Cancer Diagnostics Market, Sub Segment Analysis
7.4.1. Hospitals
7.4.2. Speciality Clinics
7.4.3. Others
Chapter 8. Global Lung Cancer Diagnostics Market, Regional Analysis
8.1. Top Leading Countries
8.2. Top Emerging Countries
8.3. Lung Cancer Diagnostics Market, Regional Market Snapshot
8.4. North America Lung Cancer Diagnostics Market
8.4.1. U.S. Lung Cancer Diagnostics Market Cancer Type breakdown estimates & forecasts, 2020-2030 Test breakdown estimates & forecasts, 2020-2030 End User breakdown estimates & forecasts, 2020-2030
8.4.2. Canada Lung Cancer Diagnostics Market
8.5. Europe Lung Cancer Diagnostics Market Snapshot
8.5.1. U.K. Lung Cancer Diagnostics Market
8.5.2. Germany Lung Cancer Diagnostics Market
8.5.3. France Lung Cancer Diagnostics Market
8.5.4. Spain Lung Cancer Diagnostics Market
8.5.5. Italy Lung Cancer Diagnostics Market
8.5.6. Rest of Europe Lung Cancer Diagnostics Market
8.6. Asia-Pacific Lung Cancer Diagnostics Market Snapshot
8.6.1. China Lung Cancer Diagnostics Market
8.6.2. India Lung Cancer Diagnostics Market
8.6.3. Japan Lung Cancer Diagnostics Market
8.6.4. Australia Lung Cancer Diagnostics Market
8.6.5. South Korea Lung Cancer Diagnostics Market
8.6.6. Rest of Asia Pacific Lung Cancer Diagnostics Market
8.7. Latin America Lung Cancer Diagnostics Market Snapshot
8.7.1. Brazil Lung Cancer Diagnostics Market
8.7.2. Mexico Lung Cancer Diagnostics Market
8.8. Middle East & Africa Lung Cancer Diagnostics Market
8.8.1. Saudi Arabia Lung Cancer Diagnostics Market
8.8.2. South Africa Lung Cancer Diagnostics Market
8.8.3. Rest of Middle East & Africa Lung Cancer Diagnostics Market

Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.1.1. Company 1
9.1.2. Company 2
9.1.3. Company 3
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. QIAGEN GmbH Key Information Overview Financial (Subject to Data Availability) Product Summary Recent Developments
9.3.2. F. Hoffmann-La Roche Ltd.
9.3.3. Thermo Fisher Scientific Inc.
9.3.4. Abbott Laboratories
9.3.5. Quest Diagnostics Incorporated
9.3.6. Biodesix Inc.
9.3.7. Amoy Diagnostics Co., Ltd.
9.3.8. Bio-Rad Laboratories, Inc.
9.3.9. Biocartis
9.3.10. Boditech Med Inc.
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com


Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.

Enquiry Now